For years, the FDA recommendation for annual prostate cancer screening has been digital prostate exams along with the PSA (Prostate-specific antigen) blood test annually starting at age 50. Recently, there has been a U.S. Preventive Services Task Force draft recommendation suggesting that the PSA test not be used for prostate cancer screening. IMSWF physicians routinely offer this test in our recommended health prevention lab profiles for men. Up to this point, the physicians haven’t changed this general recommendation, but I do agree that there is some need for discussion regarding the necessity and utility of this test. Browse the following links for more information. What is your opinion on the prostate cancer screening debate?
March 1, 2024
No Comments
